Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937

Genes and Development

Volumn 10, Issue 2, 1996, Pages 142-153

  Liu, Min ^a,b   Lee, Mong Hong ^a   Cohen, Marc ^a   Bommakanti, Madhavi ^a   Freedman, Leonard P ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

cell cycle arrest; differentiation; p21(WAF1,CIP1); U937 cells; vitamin D response element; Vitamin D3; vitamin D3 receptor

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; CD14 ANTIGEN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLOHEXIMIDE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PROTEIN P21; PROTEIN P27; THIOURIDINE;

ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA LIBRARY; GENE INDUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

EID: 0030065422     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.2.142     Document Type: Article

References (62)

1. Abe, E., C. Miyaura, H. Sakagami, M. Takeda, K Konno, T. Yamazaki, S Yoshiki, and T. Suda. 1981. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc Natl. Acad Sci. 78: 4990-4994.
2. Abe, E., C. Miyaura, H. Tanaka. 1983 1,25-dihydroxyvitamm D3 promotes the fusion of mouse aveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc. Natl. Acad. Sci. 80: 5583-5587.
3. Alroy, I., T. Towers, and L.P. Freedman. 1995. Transcriptional repression of the interleukin 2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15: 5789-5799.
4. Bar-Shavit, Z., S.L. Teitelbaum, P. Reitsma, A. Hall, L.E. Pegg, J. Trial, and A.J. Kahn. 1983. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. 80: 5907-5911.
5. Beadling, C., K.W. Johnson, and K.A. Smith. 1993. Isolation of inteileukin-2-induced immediate-early genes. Proc. Natl. Acad. Sci. 90: 2719-2723.
6. Bones, D., M.-C. Raynal, D.H. Solomon, Z. Darzynkiewicz, and Y.E. Cayre. 1989 Down-regulation of a serine protease, myeoblastin, causes growth arrest and differentiation of promyeolcytic leukemia cells. Cell 59: 959-968.
7. Breard, J., E.L. Reinherz, P.C. Kung, G. Goldstein, and S.F. Schlossman. 1980. A monoclonal antibody reactive with human peripheral blood monocytes. J. Immunol. 124: 1943-1950
8. Breitman, T., D. Selonick, and S. Collins. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. 77: 2936-2940.
9. INK4. Mol. Cell. Biol. 15: 2682-2688.
10. Cheskis, B., and L.P. Freedman. 1994. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell. Biol. 14: 3329-3338.
11. Collins, S.J. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233-1244.
12. Collins, S.J., F.W. Ruscetti, R. Gallagher, and R. Gallo. 1978. Terminal differentiation of the human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc. Natl. Acad. Sci. 75: 2458-2462.
13. Datta, R., M.L. Sherman, R.M. Stone, and D. Kufe. 1991. Expression of the jun-B gene during induction of monocytic differentiation. Cell Growth Differ. 2: 43-49.
14. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
15. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.E. Levy, R. Parsons, J.M. Trent, D. Lin, W E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
16. Evans, R.M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
17. Freedman, L.P. and B.F. Luisi. 1993. On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J. Cell. Biochem. 51: 140-150.
18. Goyert, S.M., E. Ferrero, W.J. Rettig, A.K. Yenamndra, F. Obata, and M.M. Le Beau. 1988. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239: 497-500.
19. Grosso, L.E., and H.C. Pitot. 1985. Transcriptional regulation of c-myc during chemically induced differentiation. Cancer Res. 45: 847-850.
20. 1NK4/MTS2-related CDK6 inhibitor, correlates with wild-type Rb function. Genes & Dev. 8: 2939-2952.
21. Halevy, O , B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
22. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
23. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
24. Harvey, D.M., and A.J. Levine. 1991. p53 alteration is a common event in the spontaneous immortilization of primary BALB/c murine embryo fibroblasts. Genes & Dev. 5: 2375-2385.
25. Hirai, H., M.F. Roussel, J.-Y. Kato, R.A. Ashmun, and C.J. Sherr. 1995. Novel Ink4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell. Biol. 11: 1185-1194
26. Jiang, H., J. Lin, Z.-z. Su, F.R. Collart, E. Huberman, E., and P.B. Fisher. 1994. Induction of differentiation in human promyeolytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406.
27. Kahn, A.J. and D.J. Simmons. 1975. Monocyte origins of osteoclasts. Nature 258: 325-378.
28. Koff, A., M. Ohtsuki, K. Polyak, J.M. Roberts, and J. Massagué. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260: 536-539.
29. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev. 9: 639-649.
30. Liyokawa, H., V.M. Richon, R.A. Rifkind, and P.A. Marks. 1994. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14: 7195-7203.
31. Luo, Y., J. Hurwitz, and J. Massagué. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cipl. Nature 375: 159-161.
32. MacGregor, F., G.R. Mogg, A.E. Burke, and C.T. Caskey. 1987. Histiochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicates heterogeneous expression of the bacterial gene. Somat. Cell. Mol. Genet. 13: 252-265.
33. Macleod, K.F., N. Sherry, G. Hannon, G. Beach, T. Tokino, K.W. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
34. 3-induced differentation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J. Cell. Biol. 98: 391-398.
35. Kip2, a structurally distinct member of the Cip1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev. 9: 650-662.
36. McCarthy, D.M., J. San Miguel, H.C. Freake, P.M. Green, H. Zola, D. Catowsky, and J. Goldman. 1983. 1,25-dihydroxyvitamin D3 inhibits the proliferation of human promyelocytic leukemia cell line (HL-60) cells and induces monocyte-macrophage differentiation in HL-60 and normal human bone marrow cells. Leuk. Res. 7: 51-55.
37. Missero, C., E. Calautti, R. Eckner, J. Chin, L.H. Tsai, D.M. Livingston, and G.P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. 92: 5451-5455.
38. Moore, M.A.S. 1987. Growth and maturation factors in leukemia. In Principles of cancer biotherapy (ed. R.K. Oldham), pp. 399-446. Raven Press, New York, NY.
39. Munker, R., A. Norman, A., and H.P. Koeffler. 1986. Vitamin D compounds: Effect on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest. 78: 474-480.
40. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. 87: 9995-9999.
41. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
42. Obeid, L., T. Okazaki, L.A. Karoloak, and Y.A. Hannun. 1990. Transcriptional regulation of protein kinase C by 1,25-dihydroxyvitamm D3 in HL-60 cells. J. Biol. Chem. 265: 2370-2374.
43. 3. Cancer Res. 43: 5862-5870.
44. Pagaon, M., S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
45. CIP1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
46. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
47. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
48. Reichel, H., H.P. Koeffler, and A.W. Norman. 1989. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320: 980-991.
49. Reitsma, P.H., P.G. Rothberg, S.M. Astrin, J. Trial, Z. BarShavit. 1983. Regulation of myc gene expression in HL-60 leukemia cells by a vitamin D metabolite. Nature 306: 492-494.
50. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev. 9: 1831-1845.
51. Ross, T.K., H.M. Darwish, and H.F. DeLuca. 1994. Molecular biology of vitamin D action. In Vitamins and hormones (ed. G. Litwak), pp. 281-326. Academic Press, San Diego, CA.
52. Sariban, E., T. Mitchell, and D. Kufe. 1985. Expression of the c-fms proto-oncogene during human monocytic differentiation. Nature 316: 64-66.
53. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
54. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
55. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-1024.
56. 3. Proc. Natl. Acad. Sci. 84: 199-203.
57. Steinman, R.A., B. Huffman, A. Iro, C. Guillouf, D.A. Liebermann, and M.E. El-Houseini. 1994. Induction of p21 (WAF1/ CIP1) during differentiation. Oncogene 9: 3389-3396.
58. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
59. Tsai, M.-J., and B.W. O'Malley. 1994. Molecular mechanisms of action steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
60. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
61. Zhang, H., G.J. Hannon, and D. Beach. 1994 p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.
62. Zhang, W., L. Grasso, C D. McClain, A.M. Gambel, Y. Cha, S. Travail, A.B. Deisseroth, and W.E. Mercer. 1995. p53-independent induction of WAF1/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res. 55: 668-674.